Company profile
Ardelyx, Inc.
Translating Scientific Breakthroughs into Promise for Patients
- Industry
- Biotechnology Research
- Employees
- 531
- Headquarters
- Waltham, MA
- Founded
- 2007
- LinkedIn followers
- 27,597
- Office locations
- 3
Ardelyx, Inc. company summary
Ardelyx, Inc. is a company in the Biotechnology Research industry, headquartered in Waltham, MA, founded in 2007. On LinkedIn the company has around 531 employees and 27,597 followers. The company lists 3 office locations.
What technology does Ardelyx, Inc. use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Ardelyx, Inc.
Ardelyx is a commercial-stage biopharmaceutical company focused on the development and commercialization of innovative medicines that meet significant unmet medical needs. Ardelyx has two commercial products approved in the United States, IBSRELA® (tenapanor) and XPHOZAH® (tenapanor). The company’s pipeline includes the Phase 3 development of IBSRELA for chronic idiopathic constipation (CIC) and RDX10531, a next-generation NHE3 inhibitor with potential application across multiple therapeutic areas. Ardelyx works with its partners to develop and commercialize its products outside of the United States. Community Guidelines: https://rb.gy/07ltg3
Where is Ardelyx, Inc. located?
Ardelyx, Inc. lists 3 office locations.
Compare companies similar to Ardelyx, Inc.
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Ardelyx, Inc. ardelyx.com | Biotechnology Research | 531 | 2007 | Waltham, MA |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about Ardelyx, Inc.
What does Ardelyx, Inc. do?
Ardelyx is a commercial-stage biopharmaceutical company focused on the development and commercialization of innovative medicines that meet significant unmet medical needs. Ardelyx has two commercial products approved in the United States, IBSRELA® (tenapanor) and XPHOZAH® (tenapanor). The company’s pipeline includes the Phase 3 development of IBSRELA for chronic idiopathic constipation (CIC) and RDX10531, a next-generation NHE3 inhibitor with potential application across multiple therapeutic areas. Ardelyx works with its partners to develop and commercialize its products outside of the United States. Community Guidelines: https://rb.gy/07ltg3
How many employees does Ardelyx, Inc. have?
Ardelyx, Inc. has around 531 employees on LinkedIn.
Where is Ardelyx, Inc. headquartered?
Ardelyx, Inc. is headquartered in Waltham, MA.
Where does Ardelyx, Inc. have offices?
Ardelyx, Inc. lists 3 office locations, including Waltham, MA, US; Milwaukee, Wisconsin, US; Newark, California, US.
When was Ardelyx, Inc. founded?
Ardelyx, Inc. was founded in 2007.
Build a lead list from companies like Ardelyx, Inc.
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.